Key facts
- This page summarizes Keith A. Goldan's Form 4 filing for ABEONA THERAPEUTICS INC. (ABEO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 07 Apr 2026, 08:47.
Keith A. Goldan - 01 Apr 2026 Form 4 Insider Report for ABEONA THERAPEUTICS INC. (ABEO)
- Reporting relationship
- Director
- Issuer ticker
- ABEO
- Reported as of
- 01 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Apr 2026, 08:47:16 UTC
- Prior SEC filing
- 10 Feb 2026
- Next SEC filing
- 02 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph Vazzano, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Keith A. Goldan filed Form 4 for ABEONA THERAPEUTICS INC. (ABEO) on 07 Apr 2026.
Change
- Previous filing in this sequence was filed on 10 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001495411
Primary reporting owner
Goldan Keith A.
- Relationship
- Director
- Address
- 6555 CARNEGIE AVE., 4TH FLOOR, CLEVELAND
- Signature
- /s/ Joseph Vazzano, Attorney-in-Fact
- Signature date
- 07 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ABEO
transaction
Common Stock
Award
- Transaction value
- Shares
- +32,751
- Change %
- Price
- $0.000000*
- Shares after
- 32,751
- Date
- 01 Apr 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
All of the restricted stock will vest on April 1, 2027.